Pioglitazone and metformin for increased small low-density lipoprotein in polycystic ovary syndrome: counterpoint.
Wild
Robert A
RA
D000328:Adult; D050197:Atherosclerosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D008687:Metformin / Q000627:therapeutic use*; D008875:Middle Aged; D000077205:Pioglitazone; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000175:diagnosis; D018570:Risk Assessment; D045162:Thiazolidinediones / Q000627:therapeutic use*; D016896:Treatment Outcome
D008078:Cholesterol, LDL; D045162:Thiazolidinediones; D008687:Metformin; D000077205:Pioglitazone